E Lattuada Selected Research

E Lattuada Research Topics

4	Psychotic Disorders (Schizoaffective Disorder) 01/2002 - 02/2000
4	Mood Disorders (Mood Disorder) 08/2001 - 01/2000
2	Infections 09/2010 - 10/2005
2	Insulin Resistance 02/2010 - 02/2009
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2010 - 02/2009
1	Non-alcoholic Fatty Liver Disease 02/2010
1	Progressive Multifocal Leukoencephalopathy 03/2009
1	Disease Progression 03/2009
1	Body Weight (Weight, Body) 02/2009
1	Postoperative Pain 07/2006
1	Morbid Obesity 07/2006
1	Substance-Related Disorders (Drug Abuse) 10/2005
1	Lipodystrophy 08/2003
1	Rabies (Hydrophobia) 12/2001
1	Bipolar Disorder (Manic Depressive Psychosis) 08/2001
1	Mental Disorders (Mental Disorder) 05/2000
1	Schizophrenia (Dementia Praecox) 02/2000

2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2002 - 08/2001
2	Tryptophan HydroxylaseIBA 08/2001 - 03/2001
2	Serotonin (5 Hydroxytryptamine)IBA 08/2001 - 03/2001
2	EnzymesIBA 08/2001 - 03/2001
2	Dopamine Receptors (Dopamine Receptor)IBA 05/2000 - 04/2000
1	Insulin Receptor Substrate ProteinsIBA 02/2010
1	diphosphoric acid (pyrophosphoric acid)IBA 02/2010
1	Insulin (Novolin)FDA Link 02/2010
1	Insulin ReceptorIBA 02/2010
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 02/2010
1	AntigensIBA 02/2010
1	NucleotidesIBA 02/2010
1	Mirtazapine (Rexer)FDA LinkGeneric 03/2009
1	LipidsIBA 02/2009
1	efavirenz (Sustiva)FDA Link 10/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2003
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2002
1	AntibodiesIBA 12/2001
1	Psychotropic Drugs (Psychoactive Drugs)IBA 05/2000
1	Dopamine D3 ReceptorsIBA 04/2000
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 04/2000
1	Serotonin ReceptorsIBA 02/2000
1	LithiumIBA 01/2000

1	Highly Active Antiretroviral Therapy (HAART) 09/2010
1	Length of Stay 07/2006
1	Operative Surgical Procedures 07/2006